Overview of GLP-1 Medications and Aging
Dr. Marc Siegel, a senior medical analyst, discusses findings from a University of California San Diego study on GLP-1 weight loss medications. The study examines their influence on biological aging, highlighting cardiovascular and neurological benefits along with side effects related to digestion and thyroid function.
Researchers have detected a rare but serious brain condition potentially linked to GLP-1 medications.
Neurological Risks Associated with GLP-1
Issued by Clinical Nutrition, the study identified 15 cases of Wernicke encephalopathy among GLP-1 medication users. This neurological disorder stems from severe vitamin B1 deficiency.
Patients frequently used semaglutide, labeled as Ozempic and Wegovy, and tirzepatide, branded as Mounjaro and Zepbound. Symptoms like gastrointestinal issues and nutritional problems, such as weight loss and vomiting, were prevalent.
“Drug shrinks your appetite. It doesn’t shrink your body’s requirements.” – Karthik Achari
Vitamin B1 is vital for brain function. Extreme deficiencies can result in confusion, difficulty in walking, balance and vision issues. Left untreated, it may lead to permanent neurological damage or death.
Response from Health Experts
Karthik Achari notes the rarity of the condition amongst millions of users. Despite the study’s findings, the medications’ direct causal link to the condition remains unproven.
Achari explains how the appetite suppression from GLP-1 drugs, alongside nausea and vomiting, could lead to vitamin B1 deficiency.
Nutritional Concerns with GLP-1 Usage
Erin Palinski-Wade emphasizes the importance of incorporating proper nutrition and hydration with GLP-1 treatments. The medications can dramatically reduce appetite, potentially causing under-consumption of necessary nutrients such as protein, fiber, and fluids.
Persistent vomiting or diarrhea may risk dehydration and kidney issues. Palinski-Wade advises seeking medical advice for persistent symptoms and warns against attributing all side effects solely to GLP-1 use.
In light of these findings, researchers urge further study on GLP-1 medication effects and recommend continuing prescribed medication until conclusive evidence emerges.